Airway Therapeutics Announces FDA Acceptance of IND for AT-100 in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD)
Initiating Phase 1b randomized clinical trial with initial results expected in late 2021 Potential for
Initiating Phase 1b randomized clinical trial with initial results expected in late 2021 Potential for
New York: Turning common perception upside down, researchers have found that concerns over infecting others play